Publications by authors named "Paolo Scollo"

Male infertility is a risk factor for the development of testicular germ cell tumors. In this study, we investigated microRNA profiles in seminal plasma to identify potential noninvasive biomarkers able to discriminate the men at highest risk of developing cancer among the infertile population. We compared the microRNA profiles of individuals affected by testicular germ cell tumors and healthy individuals with normal or impaired spermiograms using high-throughput technology and confirmed the results by single-assay digital PCR.

View Article and Find Full Text PDF

: Uterus transplantation (UTx) is currently the only available treatment for absolute uterine factor infertility. Deceased donors have recently emerged as a valid alternative to living donors for uterus transplantation, with similar results. : We report the first experience in Italy of uterus transplantation from deceased donors.

View Article and Find Full Text PDF

Study Objective: To evaluate the effectiveness of the Dual Wavelength Laser System (DWLS) diode laser on the treatment of ovarian endometrioma (OMA), with ablation and vaporization of the cystic capsule without performing the stripping technique, in terms of ovarian reserve and recurrence rate.

Design: Prospective, single-arm, multicenter, clinical trial.

Setting: Multicenter University Hospital.

View Article and Find Full Text PDF
Article Synopsis
  • Mayer-Rokitanski-Kuster-Hauser (MRKH) syndrome is a congenital condition leading to the absence of the uterus and upper vagina, which can result in infertility and psychological issues related to sexual activity.
  • Clinicians need proper evaluation methods to monitor patients and provide effective support for interventions like neovagina creation and uterus transplantation.
  • Studies show that creating a neovagina can improve sexual satisfaction and reduce mental health issues; however, psychological assessments are crucial, especially since some patients may experience anxiety and lower quality of life outcomes post-surgery.
View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed data from 24 deceased donor uterus transplants, finding a significant birth rate of 66%, but also a 25% rate of graft loss over time, encompassing various countries with differing success rates.
  • * The majority of recipients had MRKH syndrome, with median ages of 29.8 for recipients and 36.1 for donors; ethical concerns may be less complex for deceased donor transplants compared to living ones, highlighting the
View Article and Find Full Text PDF
Article Synopsis
  • Brain metastases are when cancer spreads to the brain, and this happens in about 50% of patients with HER2+ breast cancer, making it really hard to treat.
  • Current treatments like radiation can help but often lead to memory and thinking problems, and they don’t always work for a long time.
  • New treatments like targeted therapies and clinical trials are showing promise, and researchers are exploring better ways to help patients with HER2+ breast cancer and brain tumors.
View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) is a prevalent yet underdiagnosed condition in pregnancy, associated with various maternal and fetal complications. This review synthesizes the current evidence on the epidemiology, pathophysiology, and neurological consequences of OSA in pregnancy, along with the potential management strategies. Articles were sourced from the PubMed, EMBASE, and Cochrane databases until 2023.

View Article and Find Full Text PDF

Introduction: In recent years, generative Artificial Intelligence models, such as ChatGPT, have increasingly been utilized in healthcare. Despite acknowledging the high potential of AI models in terms of quick access to sources and formulating responses to a clinical question, the results obtained using these models still require validation through comparison with established clinical guidelines. This study compares the responses of the AI model to eight clinical questions with the Italian Association of Medical Oncology (AIOM) guidelines for ovarian cancer.

View Article and Find Full Text PDF

Uterus transplantation (UTx) is currently the only available treatment for absolute uterine factor infertility. More than 90 uterus transplantations have been performed worldwide, mostly from living donors. Living-donor (LD) UTx is a challenging surgical procedure since it poses ethical issues, and it is a high-risk and invasive surgery with higher hysterectomy-related risks compared to conventional hysterectomy.

View Article and Find Full Text PDF

Background: The study of health-related quality of life in survivors of gynecologic cancers is becoming increasingly important as 1.5 million survivors of gynecologic cancer in the United States and more are expected due to advances in diagnosis and treatment. This project investigated the perceived needs and lived experiences of survivors of gynecological cancer to help design supportive activities to be implemented in clinical practice.

View Article and Find Full Text PDF

CircRNAs are a class of non-coding RNAs able to regulate gene expression at multiple levels. Their involvement in physiological processes, as well as their altered regulation in different human diseases, both tumoral and non-tumoral, is well documented. However, little is known about their involvement in female reproduction.

View Article and Find Full Text PDF
Article Synopsis
  • PLD-Trabectedin is an approved treatment for relapsed platinum-sensitive ovarian cancer, but its effectiveness after PARP inhibitor (PARPi) treatment hasn't been thoroughly investigated.
  • A study compared outcomes of patients who had received PARPi (cases) to those who had not (controls), finding that those previously treated with PARPi had a shorter median progression-free survival (PFS) of 8 months compared to 11 months for controls.
  • Despite the PFS difference, the tolerability of PLD-Trabectedin was similar across both groups, indicating it remains a well-tolerated treatment option even for patients who have already undergone PARPi therapy.
View Article and Find Full Text PDF

Background: Different strategies have been proposed for the treatment of locally advanced cervical cancer (LACC), with different impacts on patient's quality of life (QoL). This study aimed to analyze urinary, bowel, and sexual dysfunctions in a series of LACC patients who underwent chemotherapy, radiotherapy, radical surgery, or a combination of these treatments.

Methods: Patients with LACC who underwent neoadjuvant radio-chemotherapy (NART/CT; = 35), neoadjuvant chemotherapy (NACT; = 17), exclusive radio-chemotherapy (ERT/CT; = 28), or upfront surgery (UPS; = 10) from November 2010 to September 2019 were identified from five oncological referral centers.

View Article and Find Full Text PDF
Article Synopsis
  • Oral metronomic cyclophosphamide (MOC) has shown potential as a treatment for recurrent epithelial ovarian cancer (EOC), offering disease palliation with mild to moderate toxicity, particularly in patients who have progressed after chemotherapy. !* -
  • A comprehensive review and metanalysis of literature highlighted a pooled objective response rate (ORR) of 18.8% and a disease control rate of 36.2% for MOC in treating recurrent or platinum-refractory ovarian cancer, with average progression-free survival of 3.16 months and overall survival of 8.7 months. !* -
  • The findings suggest that single-agent oral cyclophosphamide remains a viable treatment option for EOC
View Article and Find Full Text PDF

Uterine tumors resembling ovarian sex-cord tumors (UTROSCT) are thought to develop from pluripotent uterine mesenchymal cells or endometrial stromal cells with secondary sex-cord differentiation. The patient was a 73-year-old postmenopausal woman who had abnormal vaginal bleeding, and she underwent a laparoscopic hysterectomy with bilateral salpingo-oophorectomy. The diagnosis was a case of UTROSCT.

View Article and Find Full Text PDF

Background: Several pretreatment variables have been found to correlate with the clinical outcome of patients treated with NACT plus radical hysterectomy, such as FIGO stage, tumor size, and lymph node status.

Methods: A single-center retrospective observational study to evaluate the use of NACT in LACC, particularly in the lymph-node-positive subpopulation. The study, conducted at the Maternal and Child Department of "Cannizzaro Hospital" in Catania, included patients treated between 2009 and 2019.

View Article and Find Full Text PDF

BACKGROUND Important legal and ethical issues must be addressed in the practice of uterus transplantation, because it is a non-life-saving intervention. In all cases reported in the literature so far, uterus transplantation is preceded by oocyte retrieval, fertilization of the collected oocytes, and subsequent freezing of the embryos produced. This element should be considered because of the potential ethical, legal, and moral implications related to the existence and fate of supernumerary embryos in the event of transplantation failure.

View Article and Find Full Text PDF

Introduction: Metronomic oral cyclophosphamide (MOC) presents many potential advantages, such as significantly less severe side effects than standard regimens, ease of administration, and the delivery of a dose-dense but not necessarily dose-intense treatment. These observations prompted us to evaluate in a retrospective, multicenter study the efficacy and toxicity of MOC in a real-life series of pretreated cancer patients.

Methods: The study is a multicenter, retrospective analysis of the activity of single-agent MOC in patients with recurrent or residual epithelial ovarian, fallopian tube, or primary.

View Article and Find Full Text PDF

Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study (Clinical Trial ID: NCT05791838) aimed to report a retrospective analysis of the management and outcomes of 86 consecutive BOTs patients, 54 of which were at a reproductive age. All patients with BOTs undergoing surgical treatment from January 2010 to December 2017 were included.

View Article and Find Full Text PDF

Study Objective: This study aimed to evaluate the learning curve of vaginal natural orifice transuminal endoscopic surgery (vNOTES) hysterectomy in expert minimal invasive and vaginal surgery team.

Design: This is a cohort study on a retrospective analysis.

Setting: Department of Obstetrics and Gynecology of Cannizzaro Hospital in Catania Italy.

View Article and Find Full Text PDF

Background: The aim of this study is to evaluate the initial feasibility, safety, and outcomes of hysterectomy performed by transvaginal natural orifice transluminal endoscopic surgery (vNOTES) at three institutions in Italy.

Materials And Methods: All women who underwent vNOTES hysterectomy ± salpingo-oophorectomy for benign indications at three tertiary referral medical centers between July 2019 and April 2021 were included in a retrospective analysis. All vNOTESs were performed with the use of Alexis and Vpath Gel paths (Applied Medical).

View Article and Find Full Text PDF